ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 409

Antisynthetase Syndromes: Correlation of Indirect Immunofluorescence Patterns with Diagnosis Criteria Fulfillment

Martín Greco1, María Jesús García De Yébenes 2, Inmaculada Alarcón 3, Iñigo Rua Figueroa 4, Estíbaliz Loza 2, Carlos Rodriguez-Lozano 5, Anahy Brandy-Garcia 6 and Loreto Carmona 2, 1Rheumatology Department. Hospital Universitario de Gran Canaria Dr. Negrín., Las Palmas, Spain, 2Instituto de Salud Musculoesquelética - Inmusc., Madrid, Spain, 3Biochemical Department, Autoimmunity Laboratory. Hospital Universitario de Gran Canaria Dr. Negrín., Las Palmas, Canarias, Spain, 4Hospital Doctor Negrin, Las Palmas, 5Rheumatology Department. Hospital Universitario de Gran Canaria Dr. Negrín., Madrid, Spain, 6Hospital Universitari Germans Trias i Pujol, Badalona, Spain

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: diagnosis and immunology, synthetase syndrome

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 10, 2019

Title: Muscle Biology, Myositis & Myopathies Poster I

Session Type: Poster Session (Sunday)

Session Time: 9:00AM-11:00AM

Background/Purpose: The antisynthetase syndromes (ASSD) are characterized by the presence of anti-aminoacyl transfer RNA synthetase (ARS) autoantibodies and a clinical classic triad of myositis, arthritis, and interstitial lung disease (ILD). Two ASSD diagnosis criteria have been proposed; those from Connors, and the stricter from proposed by Solomon.
Regarding ARS detection, previous studies have shown differences in the specificity between different myositis immunoblots. Nevertheless, an adequate clinical correlation and the ARS positivity in another monospecific-assays or HEp-2 indirect immunofluorescence assay (IIFA), can safeguard a high specificity of myositis-specific autoantibodies in the immunoblots.
Objective:
To evaluate the performance of IIFA patterns in the ASSD diagnosis in patients with ARS positivity and adequate ASSD or IIM clinical suspicion.

Methods: We analyzed data from one center (period 06/2008-06/2018). We searched all the myositis immunoblots (Euroimmun assay) requested by Rheumatologists under suspicion of ASSD or myositis and assessed: 1) the rate of cases with positive ARS; 2) the rate of cases with Connor´s or Solomon´s diagnosis criteria fulfillment; and 3) their relation with the IIFA patterns (Hep-2 cells; ≥1/80).

Results: A total of 140 myositis immunoblots were searched. Twenty-seven cases (19.3%) presented positive ARS: anti-Jo1 (n=13), anti-PL-12 (n=7), anti-PL-7 (n=1), anti-EJ (n=2), and anti-OJ  (n=4). Twenty-five of these (92.6%) fulfilled Connors´ criteria, and 15 (55.5%) also met Solomon´s criteria. Additionally, all cases with positive ARS presented positive IIFA: 19 (70.4%) showed a cytoplasmic speckled pattern (10 of them with an associated nuclear pattern) and 8 cases (29.6%) presented only a nuclear pattern.
Correlating, 13 of 27 cases with clinical suspicion of IIM or ASSD and positive ARS (48.1%) presented a cytoplasmic speckled IIFA pattern and also fulfilled Solomon´s criteria; representing the 68.4% of the cases with these IIFA patterns and the 86.6% of those that met Solomon´s criteria.
On the other hand, 71 of the 113 cases (62.8%) with negative ARS presented positive IIF: 29 of them (40.8%) showed a cytoplasmic pattern (21 with an associated nuclear pattern) and 42 cases (59.2%) presented only a nuclear pattern.

Conclusion: Our results suggest that in patients evaluated by a Rheumatologist, with an adequate clinical suspicion of ASSD or IIM and with ARS positivity, the probability of fulfilling Solomon´s criteria is higher when the IIFA presents a cytoplasmic speckled pattern than when only a nuclear pattern is observed.
Additionally, the high rate of positive IIFA in patients without positive ARS, suggests the presence of other positive antibodies and is in favor of good clinical judgment of the Rheumatologists when requesting the tests and of the autoimmunity expert when accepted them. This highlights the importance of the International Autoantibody Standardization (IAS) and the International Consensus on Antinuclear antibodies Patterns (ICAP) initiatives; whose implementation clinical laboratories could facilitate the harmonization of these tests and consequently the development of multicenter studies.

Image 1. Correlation of clinical suspicion, antisynthetase antibodies -ASA- and indirect immunofluorescence assays -IIFA-.


Disclosure: M. Greco, None; M. García De Yébenes, None; I. Alarcón, None; I. Rua Figueroa, None; E. Loza, None; C. Rodriguez-Lozano, None; A. Brandy-Garcia, None; L. Carmona, None.

To cite this abstract in AMA style:

Greco M, García De Yébenes M, Alarcón I, Rua Figueroa I, Loza E, Rodriguez-Lozano C, Brandy-Garcia A, Carmona L. Antisynthetase Syndromes: Correlation of Indirect Immunofluorescence Patterns with Diagnosis Criteria Fulfillment [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/antisynthetase-syndromes-correlation-of-indirect-immunofluorescence-patterns-with-diagnosis-criteria-fulfillment/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/antisynthetase-syndromes-correlation-of-indirect-immunofluorescence-patterns-with-diagnosis-criteria-fulfillment/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology